103 related articles for article (PubMed ID: 16934468)
1. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
[TBL] [Abstract][Full Text] [Related]
2. De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.
van der Maarel SM; Deidda G; Lemmers RJ; van Overveld PG; van der Wielen M; Hewitt JE; Sandkuijl L; Bakker B; van Ommen GJ; Padberg GW; Frants RR
Am J Hum Genet; 2000 Jan; 66(1):26-35. PubMed ID: 10631134
[TBL] [Abstract][Full Text] [Related]
3. Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study.
Goselink RJM; Schreuder THA; van Alfen N; de Groot IJM; Jansen M; Lemmers RJLF; van der Vliet PJ; van der Stoep N; Theelen T; Voermans NC; van der Maarel SM; van Engelen BGM; Erasmus CE
Ann Neurol; 2018 Nov; 84(5):627-637. PubMed ID: 30179273
[TBL] [Abstract][Full Text] [Related]
4. Characterization of D4Z4 alleles and assessment of de novo cases in Facioscapulohumeral dystrophy (FSHD) in a cohort of Italian families.
Strafella C; Colantoni L; Megalizzi D; Trastulli G; Piorgo EP; Primiano G; Sancricca C; Ricci G; Siciliano G; Caltagirone C; Filosto M; Tasca G; Ricci E; Cascella R; Giardina E
Clin Genet; 2024 Mar; 105(3):335-339. PubMed ID: 38041579
[TBL] [Abstract][Full Text] [Related]
5. Atypical progression of motor symptoms in facio-scapulo-humeral dystrophy: clinical worsening or overlap?
Calisi D; De Rosa MA; Russo M; Sensi SL
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37247956
[TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral muscular dystrophy.
Tawil R
Neurotherapeutics; 2008 Oct; 5(4):601-6. PubMed ID: 19019312
[TBL] [Abstract][Full Text] [Related]
7. Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature.
Denny AP; Heather AK
Oxid Med Cell Longev; 2017; 2017():7020295. PubMed ID: 28690764
[TBL] [Abstract][Full Text] [Related]
8. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
[TBL] [Abstract][Full Text] [Related]
9. Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation.
McNiff MM; Hawkins S; Haase B; Bullivant J; McIver T; Mitelman O; Emery N; Tasca G; Voermans N; Diaz-Manera J
J Neuromuscul Dis; 2024; 11(2):459-472. PubMed ID: 38277300
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and support needs in children, adolescents, and young adults with facioscapulohumeral dystrophy, a mixed-method study.
Dijkstra JN; Rasing NB; Boon HTM; Altena-Rensen S; Cup EHC; Lanser A; Siemann IJ; van Engelen BG; Erasmus CE; Voermans NC
Eur J Paediatr Neurol; 2024 May; 50():64-73. PubMed ID: 38692157
[TBL] [Abstract][Full Text] [Related]
11. IL-6 and TNF are Potential Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.
Greco A; Mul K; Jaeger MH; Dos Santos JC; Koenen H; de Jong L; Mann R; Fütterer J; Netea MG; Pruijn GJM; van Engelen BGM; Joosten LAB
J Neuromuscul Dis; 2024; 11(2):327-347. PubMed ID: 38250782
[TBL] [Abstract][Full Text] [Related]
12. Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands.
Deenen JCW; Kools J; Greco A; Thewissen R; van de Put W; Lanser A; Joosten LAB; Verbeek ALM; van Engelen BGM; Voermans NC
Acta Neurol Belg; 2024 Apr; 124(2):559-566. PubMed ID: 38218752
[TBL] [Abstract][Full Text] [Related]
13. Meeting report: The 2023 FSHD International Research Congress.
Arjomand J; Gabellini D; Voermans N;
Neuromuscul Disord; 2024 Feb; 35():53-57. PubMed ID: 37978033
[TBL] [Abstract][Full Text] [Related]
14. Face to Face: deciphering facial involvement in inclusion body myositis.
Fortanier E; Delmont E; Kouton L; Corazza G; Grapperon AM; Verschueren A; Attarian S; Salort-Campana E
J Neurol; 2024 Jan; 271(1):410-418. PubMed ID: 37740740
[TBL] [Abstract][Full Text] [Related]
15. The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India.
Vishnu VY; Lemmers RJLF; Reyaz A; Mishra R; Ahmad T; van der Vliet PJ; Kretkiewicz MM; Macken WL; Efthymiou S; Dominik N; Morrow JM; Bhatia R; Wilson LA; Houlden H; Hanna MG; Bugiardini E; van der Maarel SM; Srivastava MVP
Eur J Hum Genet; 2024 Apr; ():. PubMed ID: 38664571
[TBL] [Abstract][Full Text] [Related]
16. Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review.
Chen TH; Wu YZ; Tseng YH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096728
[TBL] [Abstract][Full Text] [Related]
17. Infantile facioscapulohumeral muscular dystrophy revisited: Expansion of clinical phenotypes in patients with a very short EcoRI fragment.
Chen TH; Lai YH; Lee PL; Hsu JH; Goto K; Hayashi YK; Nishino I; Lin CW; Shih HH; Huang CC; Liang WC; Wang WF; Jong YJ
Neuromuscul Disord; 2013 Apr; 23(4):298-305. PubMed ID: 23434070
[TBL] [Abstract][Full Text] [Related]
18. Knocking Down DUX4 in Immortalized Facioscapulohumeral Muscular Dystrophy Patient-Derived Muscle Cells.
Lim KRQ; Yokota T
Methods Mol Biol; 2023; 2587():197-208. PubMed ID: 36401032
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients.
Kurashige T; Morino H; Ueno H; Murao T; Watanabe T; Hinoi T; Nishino I; Torii T; Maruyama H
J Hum Genet; 2023 Feb; 68(2):91-95. PubMed ID: 36336708
[TBL] [Abstract][Full Text] [Related]
20. Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals.
Hangül C; Karaüzüm SB; Akkol EK; Demir-Dora D; Çetin Z; Saygılı Eİ; Evcili G; Sobarzo-Sánchez E
Curr Neuropharmacol; 2021; 19(12):2276-2295. PubMed ID: 34315378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
